Last reviewed · How we verify

Lower Dose Sodium Bicarbonate

Jennifer Gassman, PhD · Phase 3 active Small molecule

Lower dose sodium bicarbonate raises blood and urine pH to reduce acid load and slow progression of chronic kidney disease.

Lower dose sodium bicarbonate raises blood and urine pH to reduce acid load and slow progression of chronic kidney disease. Used for Chronic kidney disease with metabolic acidosis.

At a glance

Generic nameLower Dose Sodium Bicarbonate
SponsorJennifer Gassman, PhD
Drug classAlkalizing agent
ModalitySmall molecule
Therapeutic areaNephrology
PhasePhase 3

Mechanism of action

Sodium bicarbonate is an alkalizing agent that buffers systemic acidosis, a known contributor to kidney disease progression. By reducing metabolic acidosis through oral supplementation at lower doses than traditional use, it may slow glomerular filtration rate decline and preserve renal function. This mechanism is particularly relevant in chronic kidney disease where acidosis accelerates tubular damage and fibrosis.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results